Optimal Healing | 合法醫療器材資訊網

TheSYNERGYXDStentcanbesafelyusedinconjunctionwithshortenedDAPTinpatientsathighriskforbleeding,basedontheresultsfromtheEVOLVE ...

View US product prescriptive information[1] for the SYNERGY XD Stent System

The HBR Indication excludes the SYNERGY XD 48mm stent. Please review the SYNERGY DFU for full instructions on DAPT. Results from different studies are not directly comparable. Information provided for educational purposes only. * In the EVOLVE Short DAPT Study, high risk bleeding subjects were defined as meeting one or more of the following criteria: ≥75 years of age and, in the opinion of the investigator, the risk of bleeding associated with >3 months of DAPT outweighs the benefit; need for chronic or lifelong anticoagulation, history of major bleeding (severe/ life threatening or moderate bleeding based on the GUSTO classification) within 12 months of the index procedure; history of stroke (ischemic or hemorrhagic); renal insufficiency (creatinine ≥2.0 mg/dl) or failure (dialysis dependent); pl...